Feb 24, 2026 05:16PM

Feb 20, 2026 11:34AM

Feb 12, 2026 10:03AM

Feb 12, 2026 07:56AM

Jan 30, 2026 11:42AM

Jan 21, 2026 04:14PM

Jan 12, 2026 01:42PM TD Cowen Reiterates Buy Rating on BridgeBio Pharma (BBIO)

Jan 12, 2026 10:31AM

Jan 6, 2026 02:11AM

Dec 22, 2025 07:06AM

Dec 21, 2025 08:00PM

Dec 11, 2025 12:58AM

Nov 10, 2025 02:33AM

Oct 30, 2025 09:39AM BridgeBio Pharma (BBIO) PT Raised to at TD Cowen as 'Attruby Beats Expectations Again'

Oct 30, 2025 06:20AM

Oct 30, 2025 05:37AM

Oct 29, 2025 04:13PM

Oct 28, 2025 06:41AM

Oct 27, 2025 01:30PM

Oct 27, 2025 10:22AM

Oct 27, 2025 09:20AM BridgeBio Pharma (BBIO) PT Raised to $90 at Evercore ISI

Oct 24, 2025 08:29AM

Oct 17, 2025 08:32AM

Sep 30, 2025 08:01AM

Sep 23, 2025 08:48AM

Sep 22, 2025 09:09AM

Sep 15, 2025 07:32AM

Sep 12, 2025 09:01AM BridgeBio Pharma (BBIO) PT Raised to $82 at UBS on ADH1 Optimism

Sep 11, 2025 08:55AM

Sep 10, 2025 02:38PM

Sep 10, 2025 10:26AM

Sep 10, 2025 10:00AM

Sep 8, 2025 07:12AM

Sep 3, 2025 06:59AM

Sep 3, 2025 06:59AM BridgeBio Pharma (BBIO) PT Raised to $70 at JPMorgan

Sep 2, 2025 06:56AM

Aug 6, 2025 01:51PM

Aug 6, 2025 06:07AM

Aug 5, 2025 05:47PM

Jul 29, 2025 04:24PM

Jul 29, 2025 08:25AM

Jul 23, 2025 07:31AM BridgeBio study finds ADH1 genetic condition underdiagnosed by 80%

Jul 21, 2025 07:29AM

Jul 18, 2025 06:54AM

Jul 14, 2025 05:46AM

Jul 14, 2025 12:54AM

Jul 11, 2025 07:45AM

Jul 9, 2025 06:04AM

Jul 3, 2025 06:43AM Cantor Fitzgerald Reiterates Overweight Rating on BridgeBio Pharma (BBIO)

Jun 30, 2025 02:27PM

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All